Germany vs Liberia: The number of people with susceptibility test result for rifampicin
Germany
1,440
in 2021
Liberia
1,486
in 2021
Germany rank
58th
Liberia rank
57th
The number of people with susceptibility test result for rifampicin over time
- Germany
- Liberia
How they compare
Liberia currently reports 1,486 against 1,440 in Germany, a difference of 46.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Liberia ahead.
Germany ranks 58th and Liberia ranks 57th of 155 countries.
Germany has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Germany | Liberia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,298 | 1,172 | 126 | Germany |
| 2020s | 1,502 | 1,204 | 298 | Germany |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Germany or Liberia?
- Liberia, at 1,486 against 1,440 in Germany as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Germany and Liberia?
- 46, with Liberia ahead.
- How many years of comparable data are there for Germany and Liberia?
- 5 years are reported by both, from 2017 to 2021.
- How do Germany and Liberia rank globally for the number of people with susceptibility test result for rifampicin?
- Germany ranks 58th and Liberia ranks 57th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.